Murine Red & Sore Eyes (Naphazoline Hydrochloride)

Naphazoline Hydrochloride, the active ingredient in Murine Red & Sore Eyes, is an alpha‑adrenergic agonist presented as an ophthalmic solution for topical use. It is used to relieve ocular redness and mild irritation by constricting conjunctival blood vessels. GNH USA supplies Murine Red & Sore Eyes as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naphazoline Hydrochloride acts as an ocular decongestant to reduce redness caused by vascular dilation. - Red eye due to minor irritation: diminishes visible redness and discomfort. - Ocular hyperemia: contracts conjunctival vessels to improve appearance of the eye. - Allergic eye irritation: provides temporary relief of redness associated with mild allergic responses.

Naphazoline Hydrochloride may cause local ocular reactions and, rarely, systemic effects.

Common Side Effects: - Transient stinging or burning sensation upon instillation. - Mild eye irritation or itching. - Temporary blurred vision. - Dryness of the ocular surface. - Mild headache.

Serious or Rare Side Effects: - Persistent ocular hypertension. - Allergic contact dermatitis of the eyelids. - Severe eye pain or vision loss. - Systemic hypertension in susceptible individuals.

Before using Murine Red & Sore Eyes, consider the following safety measures. - Contraindication: Do not use in patients with known hypersensitivity to naphazoline or any formulation component. - Caution: Avoid prolonged use beyond the recommended period to prevent rebound hyperemia. - Interaction: Use with caution in patients taking monoamine oxidase inhibitors or other vasoconstrictive agents. - Pregnancy: Safety has not been established; consult a healthcare professional before use. - Storage: Store at room temperature: keep in the original container, protect from moisture and light.

Naphazoline Hydrochloride can interact with other agents that affect vascular tone or ocular pressure.

Major Interactions (Avoid): - Concurrent use of other topical ocular decongestants: may cause excessive vasoconstriction and rebound redness. - Systemic sympathomimetic drugs (e.g., pseudoephedrine): increase risk of systemic hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: may mask changes in intra‑ocular pressure. - Antihistamine eye drops: could alter the overall ocular surface response. - MAO inhibitors: potential for heightened systemic vasoconstrictive effects.